New to LEVITY? Start here! Want to know more about who’s behind LEVITY? Check out this page. 🙏🏼 Not subscribed to the LEVITY podcast on Youtube yet? Do it here. 🎧 More of a listener? The podcast is also available on Spotify, Apple Podcasts and other places.

New startup General Control is making epigenetic editors

Modern longevity science has poured much attention, resources, and capital into epigenetics. On one side sit biological age clocks - hopeful contenders as future biomarkers. On the other is the regenerative allure of partial reprogramming with the Yamanaka factors.

But, as it turns out, the landscape is wider than that.

Subscribe to keep reading

This content is free, but you must be subscribed to LEVITY to continue reading.

Already a subscriber?Sign in.Not now

Keep Reading

No posts found